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- This is the first national, multi-centre, pragmatic RCT in a primary care setting to evaluate 
the clinical, patient-centred and cost benefit of different recall intervals. 
 
- Traditional practice of scheduling six-monthly recall appointments for patients, regardless 
of their risk of developing dental disease, does not improve oral health. A variable risk-
based recall interval is appropriate, is not detrimental to oral health and is acceptable to 
patients and dentists. 
 
- Considering the impact of the COVID-19 pandemic limiting access to dental care, this 
study provides reassurance that, for appropriate patients, intervals between check-ups 





Objective. To compare the clinical effectiveness of different frequencies of dental recall over a 
four-year period 
 
Design. A multi-centre, parallel-group, randomised controlled trial with blinded clinical outcome 
assessment. Participants were randomised to receive a dental check-up at 6-monthly, 24-
monthly, or risk-based recall intervals. A two strata trial design was used, with participants 
randomised within the 24-month stratum if the recruiting dentist considered them clinically 
suitable. Participants ineligible for 24-month recall were randomised to a risk-based or six-month 
recall interval. 
 
Setting. UK Primary Dental Care.  
 
Participants. Practices providing NHS care, and adults who had received regular dental check-
ups. 
 
Main outcome measures. The percentage of sites with gingival bleeding on probing, oral health-
related quality of life (OHRQoL), cost-effectiveness. 
 
Results. 2372 participants were recruited from 51 dental practices. 648 were eligible for the 24-
month recall stratum and 1724 participants were ineligible. There was no evidence of a significant 
difference in the mean percentage of sites with gingival bleeding on probing between 
intervention arms in any comparison. For the eligible for 24-month recall stratum: the 24-month 
versus six-month group had an adjusted mean difference of -0.91%, 95% CI (-5.02%, 3.20%); the 
24-month group versus risk-based group had an adjusted mean difference of 0.07%, 95% CI (-
3.99%, 4.12%). For the overall sample, the risk-based vs 6-month adjusted mean difference was 
0.78%, 95% CI (-1.17%, 2.72%). There was no evidence of a difference in OHRQoL (0-56 scale, 
higher score for poorer OHRQoL) between intervention arms in any comparison. For the overall 
sample, the risk-based vs 6-month effect size was -0.35, 95% CI (-1.02,0.32). There was no 
evidence of a clinically meaningful difference between the groups in any comparison in either 
eligibility stratum for any of the secondary clinical or patient reported outcomes. 
 
Conclusion: Over a four-year period, we found no evidence of a difference in oral health for 
participants allocated to a six-month or a risk-based recall interval, nor between a 24-month, six-
month or risk-based recall interval for participants eligible for a 24-month recall. However, 
patients greatly value and are willing to pay for frequent dental check-ups. 
 
(Funded by the Health Technology Assessment Programme of the National Institute for Health 
Research, Current Controlled Trials number ISRCTN95933794). 
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Background 
The original INTERVAL Trial report is published in Health Technology Assessment1, and this paper 
summarises the clinical effectiveness results. Traditionally, patients have been encouraged to 
attend dental recall appointments at regular intervals of six months between appointments, 
irrespective of the individual’s risk of developing dental disease. The principal function of the 
dental recall has been seen as the prevention and early detection of oral disease, in 
particular dental caries and periodontal disease.2 The recommendation of a six-month recall 
interval has become established practice in primary dental care in many countries,3–7 with 
dental check-ups at six-month intervals considered customary in the General Dental Service 
(GDS) in the United Kingdom since the inception of the National Health Service (NHS).  
There has been a longstanding international debate regarding the clinical effectiveness and 
cost-effectiveness of recall intervals for routine dental check-up examinations.2,3,5 In 2004 
the National Institute for Clinical Excellence (NICE) published a guideline “Dental Recall: 
Recall interval between routine dental examinations”,8 designed to aid dentists in assigning 
individualised recall intervals to patients based on their risk of developing oral disease. The 
guideline recommends an adjustable recall interval for adults, ranging from a minimum of 
three months, to a maximum interval of 24 months between recall appointments for 
patients who have repeatedly demonstrated an ability to maintain oral health. The 
recommendations are however based on low quality evidence. Systematic reviews 
investigating this key question have reported limited evidence of poor overall quality, 
concluding that there is no evidence to support or refute the practice of encouraging 
patients to attend for dental check-ups at six-month intervals.9,10 
The aim of the INTERVAL Trial was to compare the effectiveness of dental check-ups at different 




The INTERVAL Dental Recalls Trial has been previously described in the published protocol11. 
INTERVAL was a UK-wide multi-centre, parallel-group randomised controlled trial with blinded 
outcome assessment at four-year follow-up. Participants were randomised to attend for dental 
recall at one of three recall intervals - fixed-period six-month recall interval, adjustable risk-based 
recall (based on the NICE Guideline),8 and a fixed-period 24-month recall interval. Randomisation 
was conducted within two strata, with participants only randomised to the 24-month interval if 
considered clinically suitable by their recruiting dentist. Participants who were ineligible for 24-
month recall were randomised to a risk-based or six-month recall interval. 
Participants 
Dentists in the UK who provide some NHS care and all dentate adults who had attended for a 
dental check-up at least once in the previous two years and received at least some of their dental 
treatment as an NHS patient were eligible for recruitment. Patients with uncontrolled medical 
conditions or at increased risk of bleeding were excluded. 
Participating dentists represented a cross-section of practitioners operating across the UK in 
terms of urban or rural location, community-level socio-demographics, and fluoridated or non-
fluoridated communities. 
Randomisation and blinding 
Eligible and consenting patient participants were clinically examined by their dentist to 
determine suitability for randomisation to the 24-month recall arm. This decision was based 
on routine clinical examination and risk assessment. Those considered eligible for the 24-
month recall arm were randomised to one of the three intervention arms. Participants who 
were considered ineligible for the 24-month recall were randomised to either a risk-based or six-
month recall interval. 
Random allocation of participants to an intervention arm occurred via telephone, utilising 
the automated computer-generated randomisation system at the Centre for Healthcare 
Randomised Trials (CHaRT), University of Aberdeen, UK. Participants were randomised in 
equal proportions within each stratum according to a minimisation algorithm including: 
dentist, participant age, number of restored teeth, absence of gingival bleeding on probing, 
and participant exemption from dental charges. Due to the nature of the interventions, it 
was not possible to blind participants and dentists to allocated recall intervals. 
Study interventions 
Participants allocated to the fixed-period 24-month recall interval and the fixed six-month recall 
interval groups were invited to attend their dentist at the scheduled time intervals for a routine 
dental check- up. The content of this check-up remained as per current practice. 
Participants allocated to the risk-based recall interval group attended their dentist at time 
intervals determined by the evidence-based process outlined in the “2004 NICE guideline on 
Dental Recall”.8 The frequency of recall interval appropriate for an individual patient depends on 
the likelihood that specific diseases or conditions may develop or progress beyond the control of 
secondary prevention. It is therefore a multifaceted clinical decision that involves judgment and 
consideration of an individual’s multiple risk and protective factors. The recommendation was 
that the recall interval range for adults should vary from three to 24 months, according to risk. 
The essential steps of the procedure and the risk factors collected at recall examinations are 
outlined in the NICE Guideline8 and summarised in Figure 1. 
Training of the recruited dentists in determining risk-based recall interval according to the NICE 
Guideline, including setting and review of individualised patient recall intervals, was provided in 
the form of an online training package, developed specifically for this study. Dentists were 
instructed to complete this training before screening any potential patient participants for the 




Clinical outcomes were recorded by blinded outcome assessors (n=4) at the four-year follow-up 
period. Training was provided prior to clinical outcome collection and repeated halfway through 
trial outcome collection to ensure consistency of the assessment process. The primary clinical 
outcome was bleeding on probing at the gingival margin measured by running a University of 
North Carolina probe circumferentially around each tooth just within the gingival sulcus or 
pocket.12 After 30 seconds, bleeding was recorded as being present or absent on the buccal and 
lingual surfaces of each tooth and reported as the percentage of sites with bleeding. Dentists 
were advised that any periodontal screening or treatment, including scale and polish, should be 
delayed until after the trial outcome assessment. 
Patient reported outcomes were collected at baseline and annually by self-administered postal 
questionnaires. Oral health related quality of life (OHRQoL) was the primary patient reported 
outcome collected annually by postal questionnaires and measured using the Oral Health Impact 
Profile-14 (OHIP-14).13 The OHIP-14 is a 14-question oral health specific patient-centred measure 
referring to symptoms in the past 12 months which produces a score ranging from zero to 56, 
with worsening OHRQoL associated with higher scores. 
Secondary outcomes were dental caries at the enamel and dentine thresholds, periodontal 
probing depth, calculus, dental anxiety,14 oral health related knowledge and behaviours 
(including questions on toothbrushing duration and frequency and interdental cleaning), oral 
health attitudes, generic quality of life, and satisfaction with dental care. Dentists’ attitudes 
towards dental recall strategies were collected at baseline and at four years. Details on the 
assessment of secondary outcomes are provided in the published trial protocol,11 and results are 
discussed in more detail in two companion papers focusing on caries and periodontal outcomes. 
Trial oversight 
The trial was overseen by a Trial Steering Committee (TSC) and an independent Data Monitoring 
Committee. A project management group took responsibility for the accuracy and completeness 
of the data, analyses, and reporting and for the fidelity of the study to the protocol. 
Patient and Public Involvement 
Prior to the start of the INTERVAL trial, patients provided input into the trial design and in 
recruitment and communication strategies. Patient contribution was also obtained in the design 
of the trial invitation and newsletters and in the layout of patient participant questionnaires. 
Members of the public were also involved in trial oversight through membership of the TSC, 
including contribution to interpretation of the trial findings and preparation of the final report. 
Statistical analysis 
An intention-to-treat analysis was performed for the pre-specified comparisons of six-month, 
risk-based and 24-month recall (for the group eligible for a 24-month recall) and risk-based versus 
six-month recall (for the group ineligible for a 24-month recall). Outcomes collected at year four 
were analysed using a generalised linear model with a random effect for dental practice; 
outcomes collected across the four years were analysed using a mixed effects model with two 
random effects: participant and practice. A time by treatment interaction term was included in 
the models. The appropriate effect sizes and 95% confidence intervals were derived. All analyses 
were adjusted for the minimisation variables, therefore alpha was set to 0.05, two-sided. 
Missing items in scales were dealt with as recommended in the literature by their authors when 
recommendations were available. Otherwise, a complete case approach was used where, in the 
presence of any missing items in a patient's score, the score was considered missing. Continuous 
missing data at baseline was imputed for modelling purposes.15 As a sensitivity analysis, and 
assuming a missing at random mechanism, multiple imputation was used to impute primary 
outcome data for patients with missing data.16 
Subgroup analyses explored the possible modification of treatment effect by including a 
treatment-by-factor interaction in primary outcome models. Factors were: age (< 45 years, 45-
64, ≥ 65 years) and social class (exempt from payment; not exempt from payment). A post-hoc 
subgroup analysis by country was also included. Confidence intervals were calculated at 99%, 
therefore alpha was set to 0.01, two-sided. 
Routine treatment data were obtained from the NHS BSA in England, ISD in Scotland and HSCNI 
BSO in Northern Ireland for the time period of 2010 to 2018. They provided the number of 
treatment claims for dental check-ups made by dentists for each participant. This data was 
collected from the dental practice records for participants recruited in Wales. 
Sample size 
A study with 750 participants in each arm could detect a difference in bleeding scores of 4.5% at 
90% power and 5% significance level, and likewise detect a difference of 0.17 of the standard 
deviation of the OHIP-14.17 For the caries clinical outcome, assuming a standard deviation of 3.5, 
a study with 750 participants per arm could detect a 20% relative shift in white spot lesions from 
3.3 to 3.9 at 90% power and 5% significance.18 Our sample size calculations indicated we need to 
randomise 705 participants to stratum 1 (235 in each arm) and 1030 to stratum 2 (515 in each 
arm). Assuming an intra cluster correlation of 0.03, the trial had 80% power to detect a difference 
of 4.5% of gingival sites bleeding on probing. In the power calculation we have assumed a loss to 
follow-up for dentists of 10% based on the observed rates of 12 and 9% in two recent large, multi-
centre practice based RCTs.19 
Economic evaluation 
A within trial economic evaluation was conducted over the 4-year trial time horizon. Economic 
evaluations typically take the form of cost-utility (i.e. cost per Quality Adjusted Life Year (QALY)). 
However, in the context of dentistry, there are concerns that generic EQ-5D based QALYs lack 
the sensitivity to capture the processes and outcomes of care that are of value to patients and 
decision makers. Different perspectives of benefits were therefore evaluated (Willingness to pay 
(WTP)) for dental recall interval and dental health outcomes, WTP for dental health outcomes 
only, and QALYs. The perspectives for costs were NHS dental costs, all NHS costs and participant 
costs. Costs were collected using dental claims data and annual participant completed 
questionnaires. QALYs were calculated using responses to the annual participant completed EQ-
5D-3L questionnaire and valued according to UK general population tariffs. An online discrete 
choice experiment (DCE) with a nationally representative sample of the UK general population 
was used to estimate WTP tariffs which were then mapped to frequency of recall interval, 
bleeding on brushing and caries experience observed in the trial. Multiple imputation was used 
to address missing data and incremental costs and benefits were estimated using generalised 
linear regression models. 
 
Results 
Recruitment took place between July 2010 and July 2014 and follow-up closed in April 2018. The 
flow of participants in the trial is shown in Figures 2-3. Across 51 dental practices, 2,372 
participants were recruited. To the 24-month recall stratum, 648 were recruited, 217 allocated 
to the risk-based recall, 216 to the 24-month recall and 215 to the six-month recall. In the 
ineligible for 24-month recall stratum, 1,724 participants were recruited, 861 allocated to risk-
based recall and 863 to the six-month recall. In total, 1,078 participants received a risk-based 
recall and 1,078 received a six-month recall. Participant characteristics at baseline are shown in 
Table 1. The average age of participants was 45 years, the majority were women (57%) and 
regular dental attenders. The majority of the study population reported brushing their teeth at 
least twice per day (81%) and 38% used an electric toothbrush. Mean OHIP-14 scores (0-56 scale) 
were low indicating good OHRQoL in both strata - 4.4 in the eligible for 24-month recall stratum 
and 5.7 in the ineligible stratum. Overall, participants in the ineligible for 24-month recall stratum 
were older, self-reported to attend the dentist more regularly and had higher OHIP scores than 
those in the eligible stratum. There were no important differences or imbalances across 
randomised groups in each of the eligibility strata. 
 
Primary outcomes 
Overall, 416 (64%) participants within the eligible for 24-month recall stratum attended a follow-
up appointment and 460 (71%) completed a year 4 questionnaire. Within the ineligible stratum, 
1,208 (70%) participants attended a follow-up appointment and 1,305 (76%) completed a year 4 
questionnaire.  
Participants in the eligible for 24-month recall stratum were assigned recall appointments at a 
mean of 13 months (risk-based), 24 months (24-month recall) and 7 months (six-month recall). 
Participants in the ineligible for 24-month recall stratum were assigned recall appointments at a 
mean of 9 months (risk-based) and 8.5 months (six-month recall).  According to routinely 
collected data, over the four year follow-up period, participants eligible for the 24-month recall 
stratum who had a clinical outcome assessment had a mean of 3.7 (SD 1.9) check-ups in the risk-
based arm, 2.5 (SD 2.2) in the 24-month and 5.1 (SD 3.7) in the six-month recall arm. Participants 
who were ineligible for the 24-month recall who had a clinical outcome assessment had a mean 
of 5.0 (SD 2.3) check-ups during the trial in the risk-based arm and 5.4 (SD 2.0) in the six-month 
arm.  
Within the eligible for 24-month recall stratum, the percentage of sites bleeding at four years 
were: 6-month 35.6% (SD 21.7), risk-based 35.6% (SD 19.1), and 24-month 34.4% (SD 20.1). 
Within the ineligible for 24-month recall stratum, the percentage of sites bleeding at four years 
were: 6-month 32.8% (SD 22.1) and risk-based 33.4% (SD 22.2).  
The treatment effects for the primary outcomes and secondary clinical outcomes are presented 
in Table 3. At four years there was no evidence of a significant difference in gingival bleeding on 
probing between the groups in any comparison: the 24-month group versus six-month had an 
adjusted mean difference of -0.91%, 95% CI (-5.02%, 3.20%), p-value=0.66; the risk-based versus 
six-month recall had an adjusted difference of -0.98% 95% CI (-5.05%, 3.09%), p-value=0.64; the 
24-month versus risk-based had an adjusted mean difference of 0.07%, 95% CI (-3.99%, 4.12%), 
p-value=0.97. For the overall sample, the risk-based recall versus six-month recall had an 
adjusted mean difference of 0.78%, 95% CI (-1.17%, 2.72%), p-value= 0.43. Multiple imputation 
was used for the primary clinical outcome (gingival bleeding on probing) for sensitivity analysis, 
which did not change the interpretation of the results. 
Within the eligible for 24-month recall stratum, the mean OHIP-14 scores were: 6-month 4.8 (SD 
6.2), risk-based 4.1 (SD 5.7), and 24-month 4.8 (SD 6.4). Within the ineligible for 24-month recall 
stratum, the mean OHIP-14 scores were: 6-month 5.8 (SD 8.3) and risk-based 5.5 (SD 6.8). Table 
2 summarises results for the trial primary outcomes and secondary clinical outcomes. The results 
for other secondary outcomes are presented in Table S1. 
There was no evidence of a difference across comparisons for OHRQoL between the groups in 
any comparison: the 24-month group versus six-month had an effect size of -0.24 95% CI (-
1.55,1.07), p-value=0.72; the risk-based versus six-month recall had an effect size of -0.61 95% 
CI (-1.93,0.71), p-value=0.37; the 24-month versus risk-based had an effect size of 0.37 95% CI 
(-0.95,1.69), p-value=0.58. For the overall sample the risk-based recall versus six-month recall 




The remaining treatment effects for the secondary clinical outcomes are presented in the same 
Table 3 and secondary patient-reported outcomes in Table S2. There was no evidence of a 
clinically meaningful difference between the groups in any comparison in either eligibility 
stratum for any outcome. 
 
Subgroup analyses 
Figures 4-5 show the means and 99% confidence intervals for the differences in gingival bleeding 
on probing at four years in the subgroups for recall frequency and stratum respectively. In 
England, in the eligible to a 24-month recall stratum, participants randomised to a six-month 
recall showed a significant improvement compared with those randomised to a risk-based recall 
(mean difference 4.98 95% confidence interval (1.14, 8.83), p-value<0.001). There was no 
evidence of treatment modification amongst the pre-specified subgroups (Figure 4 and 5). 
Dentist’s attitude regarding a 24-month recall improved between baseline and follow-up, as did 
their attitude regarding six- month recall. Where dentists considered at least one patient eligible 
for the 24-month recall interval (n=40), a slight increase was seen in their perceived ability to 
judge risk. Where dentists did not consider any patient eligible for a 24-month recall (n=6) a 
decrease in their perceived ability to judge risk was seen. 
 
Economic Evaluation 
The economic evaluation results varied depending on the perspective of benefits considered.   
The DCE showed that the general population were willing to pay to avoid progressive levels of 
dental decay and bleeding gums but were also willing to pay for (and highly valued) more 
frequent recalls.  Including all sources of utility to the general population (health and non-health), 
six-monthly recalls generated the greatest net benefit (cost less WTP) and the finding was 
consistent across sensitivity analyses undertaken. 
When restricting the scope of benefit valuation to dental outcomes only (i.e. WTP for bleeding 
on brushing and caries experience only), 24-month recall is the most likely optimal strategy, with 
a probability of positive net dental health benefit (cost less WTP for dental health outcomes)  
ranging between 65% and 99% across a range of sensitivity analyses conducted.  Results are 
driven by potential for significant cost savings when considering the cost burden to participants 
and the NHS combined, with no evidence of a difference in clinical outcomes.  For the trial 
population as a whole (including both eligible and ineligible for 24-month recall stratum), there 
is substantial uncertainty regarding the most efficient strategy (risk based or six-monthly) to 
maximise dental health benefit.  Risk based recalls were more likely to generate positive net 
dental health benefit when a wider perspective (NHS + participant) of the costing analysis was 
considered.  
The optimal recall was unclear when evaluating cost per QALY gained, due in part to the lack of 
sensitivity of the generic EQ-5D to capture dental outcomes. In the combined analysis across both 
trial strata, no strategy achieved a probability of cost-effectiveness greater than 70% at a 
threshold value of society’s WTP for a QALY gain of £20,000.  The probability of cost-effectiveness 
was higher for the 24 months recall strategy in the analysis restricted to the eligible stratum due 
to the potential for cost savings associated with longer recall intervals for the minority of 




This is the first national, multi-centre, pragmatic RCT in a primary care setting to evaluate the 
clinical, patient-centred and cost benefit of different recall intervals. The INTERVAL Trial 
investigated the implementation of a risk variable approach to recall as recommended in the 
NICE guideline on Dental Recall. The guideline considers the effect of dental recalls on patients’ 
wellbeing, general health and preventive habits, as well as caries incidence, the need for 
restorative treatment, patients’ periodontal health, maintenance of dentition, and avoidance of 
pain and dental anxiety. It aims to improve or maintain patients’ quality of life and reduce 
morbidity associated with oral disease. This guideline was initially published in 2004 and most 
recently reviewed in 2018, confirming there was no emerging evidence to change the 
recommendations. Challenges to assumed routine dental practice such as the six- month dental 
recall and the benefit of regular scale and polish were voiced as early as 1977.2 The mantra of a 
six-month recall has been in existence for decades and trying to establish the scientific basis for 
a six-month or a variable risk-based recall interval was the reason for this trial. Contemporary 
healthcare supports a patient centred, appropriate, preventive, and compassionate approach 
and a dental recall visit is the opportunity for oral disease to be diagnosed early and preventive 
advice and therapy to be provided. The aim of this RCT in primary care dental practice was to 
provide evidence for the benefit or harm of dental check- ups at different recall intervals on 
maintaining oral health. 
This study has shown that a variable risk-based recall interval is appropriate, is not detrimental 
to oral health and is acceptable to patients and dentists. Over a four-year period, we found no 
difference in oral health for patient participants allocated to a six-month or a variable risk-based 
interval. Nor did we find a difference between the intervals of 24-month, six-month and risk-
based for the 30% of adults considered suitable to be recalled at 24 months by their dentist. 
Extending the recall from six-months had no effect on patient reported OHRQoL and the 
participants were satisfied being allocated to a recall interval based on risk. No evidence of a 
difference was found in any of the secondary clinical outcomes measured between the three 
recall intervals for those eligible for 24-month recall or the overall six-month and risk-based 
groups. The secondary clinical outcomes were coronal caries measured at three thresholds 
(initial, moderate and extensive), presence of root surface caries, mean periodontal probing 
depth and presence of calculus. 
Participants deemed eligible to be allocated to a 24-month recall had, on average, a better 
OHRQoL score than those deemed ineligible. Participants deemed ineligible were more likely to 
identify themselves as regular attenders. This suggests participating dentists were already 
reliably assessing patient’s oral health risk and our study shows potential for cost savings to the 
NHS and participants of extending dental recalls to 24 months for the minority of patients who 
are deemed eligible. 
A recent correspondence article in the Lancet commented on the extraordinary impact of the 
COVID-19 global pandemic on dental services worldwide, which essentially closed down for five 
months, limiting access even to emergency dental care.20 As dental services tentatively re-open, 
with guidance on safety procedures to follow, the issue of reduced access to dental care may be 
a challenge for dental services and patients for some time. There is therefore an impetus to 
reform dental services to meet the challenges of prioritising care for high need demographics 
and pursuing a minimally invasive prevention-orientated practice in light of the restrictions on 
aerosol generating procedures. Serious consideration must also be given to ceasing ineffective 
treatments that utilise valuable resources without improving health outcomes. The results of this 
study provide important supporting evidence that intervals between dental recall appointments 
can be extended beyond six months without detriment to the oral health of patients. 
 
Limitations 
The decision on the recall interval to allocate a participant to the risk-based recall arm was made 
by the recruiting dentist. Training on determining recall interval based on an individual’s risk of 
developing dental disease was provided according to NICE guidelines, however the process of 
assessing risk and the factors considered in making this decision was not operationalised for 
collection. Similarly, factors considered by dentists in determining eligibility to the 24-month 
recall arm were not assessed and collected. 
INTERVAL had a drop-out of 25-30% in the questionnaire data and 30-37% in attendance of 
follow-up appointments, a higher value than expected at the design stage of the trial. However, 
the drop-out rates were balanced between the arms and sensitivity analyses using multiple 
imputation showed the results were robust. 
 
Conclusions 
This trial compares the clinical effectiveness of frequency of dental recall appointments in 
primary dental care over four years. It comes to the controversial conclusion that there is no 
clinical benefit of a six-monthly recall compared to a risk-based recall or 24-month recall in those 
patients considered eligible. The absence of evidence of a difference between the three recall 
strategies therefore indicates a variable risked based recall interval can be supported as it is not 
detrimental to oral health. The current evidence therefore suggests that current practice of 
scheduling six-monthly recall appointments for patients, regardless of their risk of developing 
dental disease, does not improve oral health.  This could be considered an inefficient use of scarce 
NHS resources, adding unnecessary patient costs for no gain in dental health outcomes, 
particularly for the subgroup of patients who are deemed suitable for longer 24-month recall 
intervals. However, six-monthly recalls are highly valued by the general population and moving 
towards a personalised, variable recall strategy will require the cooperation of health care policy 
makers, clinicians’ practise and patients. 
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Table 1: Participant characteristics at baseline by eligibility stratum and randomised arm 
 Eligible for 24-month recall Ineligible for 24-month recall 
 Risk-based (n=217) 24-month (n=216) 6-month (n=215) Risk-based (n=861) 6-month (n=863) 
Baseline questionnaire returned 181 (83.4) 186 (86.1) 187 (87.0) 810 (94.1) 803 (93.0) 
Age mean (SD), n 43.3 (15.1),217 44.2 (15.2),216 43.5 (14.5),215 49.3 (14.1),861 50.1 (15.3),863 
 Male - n (%) 87 (40.1) 100 (46.3) 94 (43.7) 356 (41.3) 366 (42.4) 
 Female - n (%) 128 (59.0) 115 (53.2) 121 (56.3) 498 (57.8) 491 (56.9) 
Missing 2 (0.9) 1 (0.5) 0 (0) 7 (0.8) 6 (0.7) 
Smoked in the last 12mo - n (%) 32 (14.7) 27 (12.5) 32 (14.9) 145 (16.8) 130 (15.1) 
Missing 38 (17.5) 32 (14.8) 30 (14.0) 53 (6.2) 69 (8.0) 
Regular attender - self-report - n (%) 158 (72.8) 163 (75.5) 168 (78.1) 740 (85.9) 735 (85.2) 
Missing 39 (18.0) 31 (14.4) 28 (13.0) 60 (7.0) 71 (8.2) 







Table 2: Outcome measures at four years, by eligibility stratum and randomised arm 
 Eligible for 24-month recall Ineligible for 24-month recall 
 Risk-based 24-month 6-month Risk-based 6-month 
Attended clinical follow-up - n 143  138 135 606 602 
Gingival Bleeding – mean percentage of sites 
bleeding on probing – mean (SD), count 
35.6 (19.1), 142 34.4 (20.1), 137 35.6 (21.7), 134 33.4 (22.2), 599 32.8 (22.1), 597 
OHIP-14 score - mean (SD), count 4.1 (5.7), 145 4.8 (6.4), 153 4.8 (6.2), 152 5.5 (6.8), 624 5.8 (8.3), 630 
Calculus – mean percentage of surfaces with 
calculus – mean (SD), count 
34.1 (26.0), 142 38.2 (28.3), 138 37.4 (24.9), 133 37.3 (27.8), 604 38.0 (27.8), 600 
Mean pocket depth (mm) – mean (SD), count 2.2 (0.5), 142 2.1 (0.3), 137 2.1 (0.4), 133 2.2 (0.4), 594 2.2 (0.4), 594 
Mean no of surfaces with caries – mean (SD), 
count 
     
Any caries 15.5 (9.8), 143 14.1 (7.9), 138 14.7 (8.4), 135 14.7 (8.9), 606 14.7 (9.2), 602 
Initial lesions 12.4 (8.8), 143 11.7 (7.4), 138 12.4 (7.5), 135 11.2 (7.5), 606 11.3 (7.8), 602 
Moderate lesions 2.8 (2.5), 143 2.1 (1.9), 138 2.2 (2.2), 135 3.1 (3.1), 606 3.0 (3.0), 602 






Table 3: Treatment effects for the primary outcomes and secondary clinical outcomes at four-
year follow-up 
Outcome Comparison Effect size (95% CI), p-value 
Eligible for 24-month stratum   
Gingival Bleeding – mean percentage of sites bleeding on 
probing 
24-month vs six-month  -0.91 (-5.02,3.20), 0.66 
Risk-based vs six-month -0.98 (-5.05,3.09), 0.64 
24-month vs risk-based  0.07 (-3.99,4.12), 0.97 
OHIP-14 score 24-month vs six-month  -0.24 (-1.55,1.07), 0.72 
Risk-based vs six-month -0.61 (-1.93,0.71), 0.37 
24-month vs risk-based  0.37 (-0.95,1.69), 0.58 
Calculus - mean percentage of surfaces with calculus 24-month vs six-month  0.19 (-5.46,5.83), 0.95 
Risk-based vs six-month -2.92 (-8.52,2.67), 0.31 
24-month vs risk-based  3.11 (-2.45,8.67), 0.27 
Mean pocket depth (mm) 24-month vs six-month  -0.03 (-0.12,0.06), 0.51 
Risk-based vs six-month 0.07 (-0.02,0.15), 0.14 
24-month vs risk-based  -0.10 (-0.18,-0.01), 0.03 
Most serious level of caries found per person Risk-based vs six-month 1.58 (0.96,2.62), 0.07 
24-month vs six-month  1.38 (0.83,2.29), 0.22 
24-month vs risk-based  0.87 (0.53,1.44), 0.59 
Root caries 24-month vs risk-based  0.86 (0.40,1.83), 0.70 
Risk-based vs six-month 1.69 (0.75,3.78), 0.20 
24-month vs six-month  1.45 (0.64,3.32), 0.37 
Overall sample (eligible and ineligible for 24-month recall 
stratum) 
  
Gingival Bleeding – mean percentage of sites bleeding on 
probing 
Risk-based vs six-month 0.78 (-1.17,2.72), 0.43 
OHIP-14 score (0-56 scale; higher score indicates worse 
OHRQoL) 
Risk-based vs six-month -0.35 (-1.02,0.32), 0.30 
Calculus - mean percentage of surfaces with calculus Risk-based vs six-month -1.30 (-3.68,1.08), 0.29 
Mean pocket depth (mm) Risk-based vs six-month 0.03 (-0.01,0.07), 0.14 
Most serious level of caries found per person Risk-based vs six-month 1.18 (0.96,1.46), 0.12 






Figure 1: The NICE risk-based dental recall procedure and risk factors.  
 
 
© NICE 2004 Dental Recall – Recall interval between routine dental examinations. Available 
from https://www.nice.org.uk/guidance/cg19/evidence/full-guideline-pdf-193348909. All 
rights reserved. Subject to Notice of rights. Figure 1 is reproduced by kind permission from 
the National Institute for Health and Care Excellence (NICE). NICE guidance is prepared for the 
National Health Service in England. All NICE guidance is subject to regular review and may be 










Figure 2: Consolidated Standards of Report Trials (CONSORT) diagram for participants eligible 
for 24-month recall stratum 
Figure 3: Consolidated Standards of Report Trials (CONSORT) diagram for participants 
ineligible for 24-month recall stratum 
Figure 4:  Subgroup results for recall allocation in the eligible for 24-month recall stratum for 
percentage of sites bleeding on probing: difference between arms, by subgroup 
 
 
Figure 5:  Subgroup results for recall allocation in the overall sample (eligible and ineligible 










 Eligible for 24-month recall Ineligible for 24-month recall 
 Risk-based 24-month 6-month Risk-based 6-month 
Attended clinical follow-up - n 143  138 135 606 602 
Most advanced carious lesion per 
person – n (%) 
     
▪ Sound surfaces 
(ICDAS 0) 
1 (0.7) 1 (0.7) 0 (0) 3 (0.5) 8 (1.3) 
▪ Initial lesions 
(ICDAS 1-2) 
22 (15.4) 28 (20.3) 33 (24.4) 100 (16.5) 107 (17.8) 
▪ Moderate lesions 
(ICDAS 3-4) 
98 (68.5) 87 (63.0) 87 (64.4) 393 (64.9) 376 (2.5) 
▪ Extensive caries or 
treatment needed 
(ICDAS 5-6) 
20 (14.0) 22 (15.9) 13 (9.6) 110 (18.2) 107 (17.8) 
▪ Missing 2 (1.4) 0 (0) 2 (1.5) 0 (0) 4 (0.7) 
Root caries – n (%)      
Yes 26 (18.2) 21 (15.2) 17 (12.6) 121 (20.0) 137 (22.8) 
No 99 (69.2) 101 (73.2) 99 (73.3) 417 (68.8) 390 (64.8) 
Missing 18 (12.6) 16 (11.6) 19 (14.1) 68 (11.2) 75 (12.5) 
Table S2: Treatment effects for the secondary outcomes at four-year follow-up 
Outcome / status Comparator Effect size 95% CI, p-value 
Eligible for 24-month recall stratum 
Anxiety Risk-based vs six-month -0.31 (-1.22,0.61), 0.51 
24-month vs six-month  0.02 (-0.90,0.93), 0.97 
24-month vs risk-based  0.32 (-0.60,1.24), 0.49 
Attitude Risk-based vs six-month 0.15 (-0.03,0.32), 0.11 
24-month vs six-month  0.17 (-0.01,0.35), 0.06 
24-month vs risk-based  0.02 (-0.15,0.20), 0.79 
Behaviour Risk-based vs six-month 0.01 (-0.02,0.04), 0.53 
24-month vs six-month  0.00 (-0.03,0.03), 0.89 
24-month vs risk-based  -0.01 (-0.04,0.02), 0.62 
Knowledge Risk-based vs six-month -0.03 (-0.06,0.01), 0.10 
24-month vs six-month  -0.01 (-0.05,0.02), 0.42 
24-month vs risk-based  0.01 (-0.02,0.05), 0.41 
Perceived behavioural control Risk-based vs six-month 0.30 (-0.02,0.61), 0.06 
24-month vs six-month  0.09 (-0.22,0.40), 0.59 
24-month vs risk-based  -0.21 (-0.52,0.10), 0.19 
Satisfaction Risk-based vs six-month 0.05 (-0.10,0.20), 0.51 
24-month vs six-month  -0.11 (-0.26,0.04), 0.16 
24-month vs risk-based  -0.16 (-0.31,-0.01), 0.04 
Self-reported bleeding Risk-based vs six-month -0.16 (-0.37,0.06), 0.15 
24-month vs six-month  -0.22 (-0.43,-0.01), 0.04 
24-month vs risk-based  -0.06 (-0.28,0.15), 0.57 
EQ5-D Risk-based vs six-month 0.032 (-0.013, 0.076), 0.165 
24-month vs six-month  0.024 (-0.021, 0.069), 0.290 
24-month vs risk-based  -0.008 (-0.053, 0.037), 0.741 
Overall sample (eligible and ineligible for 24-month recall) 
Anxiety Risk-based vs six-month -0.11 (-0.52,0.29), 0.59 
Attitude Risk-based vs six-month 0.04 (-0.04,0.11), 0.38 
Behaviour Risk-based vs six-month 0.00 (-0.01,0.02), 0.52 
Knowledge Risk-based vs six-month -0.01 (-0.03,0.00), 0.15 
Perceived behavioural control Risk-based vs six-month 0.06 (-0.08,0.20), 0.38 
Satisfaction Risk-based vs six-month 0.03 (-0.03,0.09), 0.31 
Self-reported bleeding Risk-based vs six-month -0.02 (-0.12,0.08), 0.72 
EQ5-D Risk-based vs six-month 0.008 (-0.012, 0.029), 0.432 
 
Note: effect size represents mean difference. The models are adjusted for protocol minimisation 
variables and have a random effect for centre. For all variables except behaviour, knowledge, 
perceived behaviour control and self-reported bleeding the mixed effects model also has a 
random effect for participant and an interaction time*treatment effect. The effect size presented 
corresponds to the treatment effect at four years. 
